Sumitomo Pharma America, Inc. (SMPA) today presented new clinical data supporting further development of enzomenib, an investigational, oral selective menin inhibitor being researched for the ...
AI is not about replacing the human element in healthcare; it’s about augmenting it. By handling complex data analysis and pattern recognition, AI frees up medical professionals to focus more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback